Novartis International AG / Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna? . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely...
Source : http://www.romandie.com/news/Novartis-Internationa...
Source : http://www.romandie.com/news/Novartis-Internationa...